Increased platelet-monocyte aggregates and cardiovascular disease in end-stage renal failure patients

Nephrology Dialysis Transplantation

Volumn 18, Issue 10, 2003, Pages 2088-2096

  Ashman, Neil ^a   Macey, Marion G ^a   Fan, Stanley L ^a   Azam, Urooj ^a   Yaqoob, Muhammad M ^a  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

CD62P; Dialysis; Platelet monocyte aggregates; Platelets; PSGL 1

Indexed keywords

P SELECTIN GLYCOPROTEIN LIGAND 1; PADGEM PROTEIN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL INTERACTION; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FLOW CYTOMETRY; HEMODIALYSIS; HUMAN; IMMUNOFLUORESCENCE; KIDNEY FAILURE; LEUKOCYTE AGGREGATION; MALE; MONOCYTE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; UREMIA;

BIOLOGICAL MARKERS; BLOOD CHEMICAL ANALYSIS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CELL AGGREGATION; FEMALE; FLOW CYTOMETRY; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MEMBRANE GLYCOPROTEINS; MONOCYTES; P-SELECTIN; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PLATELET COUNT; PLATELET MEMBRANE GLYCOPROTEINS; PREDICTIVE VALUE OF TESTS; PROBABILITY; PROGNOSIS; REFERENCE VALUES; RENAL DIALYSIS; SEVERITY OF ILLNESS INDEX;

EID: 0141841746     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfg348     Document Type: Article

References (25)

1. Herzog CA, Ma JZ, Collins AJ. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med 1998; 339: 799-805
2. Foley RN, Parfrey PS, Sarnak MI. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 1998; 9 [Suppl 12]: S16-S23
3. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115-126
4. McEver RP. Adhesive interactions of leukocytes, platelets and the vessel wall during hemostasis and inflammation. Thromb Haemostasis 2000; 86: 746-756
5. Van der Wal AC, Becker AE. Atherosclerotic plaque rupture - basis of plaque stability and instability. Cardiovasc Res 1999; 41: 344-354
6. Freedman JE, Loscalzo J. Platelet-monocyte aggregates: bridging thrombosis and inflammation. Circulation 2002; 105: 2130-2132
7. Furman MI, Barnard MR, Krueger LA et al. Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction. J Am Coll Cardiol 2001; 38: 1002-1006
8. Schomig M, Eisenhardt A, Ritz E. The microinflammatory state of uremia. Blood Purif 2000; 8: 327-332
9. Zimmermann J, Herrlinger S, Pruy A et al. Inflammation enhances cardiovascular risk and mortality in haemodialysis patients. Kidney Int 1999; 55: 648-658
10. Gawaz MP, Mujasi SK, Schmidt B, Gurland HJ. Platelet-leukocyte aggregation during hemodialysis. Kidney Int 1994; 46: 489-495
11. Carreno MP, Stuard S, Bonomini M et al. Cell-associated adhesion molecules as early markers of bioincompatibility. Nephrol Dial Transplant 1996; 11: 2248-2257
12. Bonomini M, Sirolli V, Stuard S, Settefrati N. Interactions between platelets and leukocytes during hemodialysis. Artif Organs 1999; 23: 23-28
13. Stuard S, Carreno MP, Poignet JL et al. A major role for CD62P/CD15s interaction in leukocyte margination during hemodialysis. Kidney Int 1995; 48: 93-102
14. Kim YR, Ornstein L. Isovolumetric sphering of erythrocytes for more accurate and precise cell volume measurements by flow cytometry. Cytometry 1983; 3: 419-427
15. Macey MG, Carty E, Webb L et al. Use of mean platelet component to measure platelet activation on the ADVIA 120 haematology system. Cytometry 1999; 38: 250-255
16. Fluck RJ, McMahon AC, Alameddine FM, Dawnay AB, Baker LRI, Raine AE. Platelet cytosolic free calcium concentration and parathyroid hormone: changing relationships with haemodialysis in end-stage renal disease. Clin Sci (Lond) 1992; 82: 651-658
17. Palabrica T, Lobb R, Furie RC et al. Leucocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature 1992; 81: 62-69
18. Yang J, Furie BC, Furie B. The biology of P-selectin glycoprotein ligand-1: its role as a selectin counterreceptor in leukocyte-endothelial and leukocyte-platelet interaction. Thromb Haemostasis 1999; 81: 1-7
19. Hoffman M, Monroe DM. A cell-based model of hemostasis. Thromb Haemostasis 2001; 85: 958-965
20. Furie B, Furie BC, Flaumenhaft R. A journey through P-selectin: the molecular basis of granule secretion, signalling and cell adhesion. Thromb Haemostasis 2001; 86: 214-221
21. Sarma J, Laan CA, Alam S et al. Increased platelet binding to circulating monocytes in acute coronary syndromes. Circulation 2002; 105: 2166-2171
22. Furman MI, Benoit SE, Barnard MR et al. Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease. J Am Coll Cardiol 1998; 31: 352-358
23. Michelson AD, Barnard MR, Krueger LA et al. Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin. Circulation 2001; 104: 1533-1537
24. Heeschen C, Dimmeler S, Hamm CW et al. Soluble CD40 ligand in acute coronary syndromes. N Engl J Med 2003; 348: 1104-1111
25. Huo Y, Schober A, Forlow SB et al. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med 2003; 9: 61-67